Hiroeki Sahara Selected Research

Hiroeki Sahara Research Topics

Disease

20	Neoplasms (Cancer) 01/2021 - 01/2002
4	Synovial Sarcoma (Synovioma) 01/2005 - 08/2002
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 08/2008
2	Ischemia 01/2015 - 07/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2009 - 08/2002
2	Necrosis 05/2008 - 01/2007
1	Carcinoma (Carcinomatosis) 03/2019
1	Hypoxia (Hypoxemia) 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Peripheral Arterial Disease 01/2015
1	Intermittent Claudication 01/2015
1	Infections 08/2012
1	Distemper (Canine Distemper) 08/2012
1	Infectious Canine Hepatitis (Canine Hepatitis, Infectious) 08/2012
1	Body Weight (Weight, Body) 08/2008
1	Reperfusion Injury 07/2007
1	Hemorrhage 01/2007
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2003
1	Osteosarcoma (Osteogenic Sarcoma) 01/2003
1	Genetic Translocation (Chromosomal Translocation) 12/2002
1	Squamous Cell Carcinoma of Head and Neck 08/2002
1	Ocular Paraneoplastic Syndromes 07/2002
1	Autoimmune Diseases (Autoimmune Disease) 07/2002
1	Signet Ring Cell Carcinoma 05/2002
1	Adenocarcinoma of Lung 01/2002

Drug/Important Bio-Agent (IBA)

7	Peptides (Polypeptides)IBA 01/2005 - 05/2002
4	AntigensIBA 04/2009 - 05/2002
3	HLA-A Antigens (HLA-A)IBA 01/2005 - 05/2002
3	HLA-A24 AntigenIBA 07/2004 - 07/2002
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 08/2008
2	Pharmaceutical PreparationsIBA 01/2015 - 01/2007
2	1- mono- O- acyl- 3- O- (alpha- D- sulfoquinovosyl)- glycerideIBA 08/2012 - 05/2008
2	VaccinesIBA 08/2012 - 04/2009
2	Cancer VaccinesIBA 04/2009 - 05/2002
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 08/2008 - 01/2007
2	GlycolipidsIBA 08/2008 - 01/2007
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Radiation-Sensitizing AgentsIBA 01/2021
1	pyrenocine AIBA 12/2019
1	sulfoquinovosylacylpropanediolIBA 03/2019
1	RNA Helicases (RNA Helicase)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Cilostazol (Pletal)FDA LinkGeneric 01/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2015
1	Small Interfering RNA (siRNA)IBA 08/2012
1	Thrombospondin 1IBA 08/2012
1	Phenobarbital (Luminal)FDA Link 07/2011
1	Keratins (Keratin)IBA 07/2011
1	Complementary DNA (cDNA)IBA 05/2009
1	Interleukin-16 (Interleukin 16)IBA 05/2009
1	Interleukin-10 (Interleukin 10)IBA 05/2009
1	Biological ProductsIBA 04/2009
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2008
1	Cyclin EIBA 08/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2008
1	sulfonoglycolipidIBA 07/2007
1	sulfoquinovosylacylglycerolIBA 07/2007
1	Liposomes (Liposome)IBA 07/2007
1	dehydroaltenusinIBA 01/2007
1	DNA Polymerase I (Klenow Fragment)IBA 01/2007
1	Angiogenesis InhibitorsIBA 02/2006
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2002
1	RecoverinIBA 07/2002
1	AcidsIBA 05/2002
1	HLA-A31 antigenIBA 05/2002
1	peptide F4.2IBA 05/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2002
1	sulfolipidsIBA 01/2002

Therapy/Procedure

5	Immunotherapy 04/2009 - 05/2002
1	Radiotherapy 01/2021
1	Therapeutics 09/2020
1	Intravenous Injections 03/2019
1	Intravenous Administration 03/2019
1	Subcutaneous Injections 08/2008
1	Oral Administration 08/2008